Retreatment with carboplatin and paclitaxel for recurrent endometrial cancer: A retrospective study of the Memorial Sloan Kettering Cancer Center experience

Women with endometrial cancer (EC) frequently receive adjuvant paclitaxel and carboplatin (PC) chemotherapy. There is no standard first line chemotherapy at disease recurrence. Data extrapolated from ovarian cancer has suggested that patients with recurrent EC may benefit from further platinum-based...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gynecol Oncol Rep
Hauptverfasser: Rubinstein, Maria, Halpenny, Darragh, Makker, Vicky, Grisham, Rachel N., Aghajanian, Carol, Cadoo, Karen
Format: Artigo
Sprache:Inglês
Veröffentlicht: Elsevier 2019
Schlagworte:
Case Series
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6461565/
https://ncbi.nlm.nih.gov/pubmed/31011610
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gore.2019.04.002
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge